INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,279,876 | +26.0% | 209,104 | +5.3% | 0.00% | +50.0% |
Q2 2023 | $4,189,532 | +19.9% | 198,556 | -3.1% | 0.00% | 0.0% |
Q1 2023 | $3,492,948 | -14.6% | 204,865 | +0.1% | 0.00% | -33.3% |
Q4 2022 | $4,089,087 | +0.9% | 204,659 | +10.1% | 0.00% | 0.0% |
Q3 2022 | $4,051,058 | +14.1% | 185,946 | +4.6% | 0.00% | +50.0% |
Q2 2022 | $3,550,638 | -10.3% | 177,750 | +3.6% | 0.00% | -33.3% |
Q1 2022 | $3,959,369 | +145.5% | 171,521 | +190.2% | 0.00% | +200.0% |
Q4 2021 | $1,613,000 | -0.8% | 59,114 | +0.1% | 0.00% | 0.0% |
Q3 2021 | $1,626,000 | -1.5% | 59,038 | +1.7% | 0.00% | 0.0% |
Q2 2021 | $1,651,000 | -14.7% | 58,024 | +2.1% | 0.00% | -50.0% |
Q1 2021 | $1,936,000 | -3.6% | 56,833 | -5.8% | 0.00% | 0.0% |
Q4 2020 | $2,009,000 | +7.4% | 60,359 | +3.7% | 0.00% | 0.0% |
Q3 2020 | $1,871,000 | +16.1% | 58,204 | -3.0% | 0.00% | 0.0% |
Q2 2020 | $1,611,000 | +77.6% | 59,981 | +6.0% | 0.00% | +100.0% |
Q1 2020 | $907,000 | -29.0% | 56,586 | +5.8% | 0.00% | 0.0% |
Q4 2019 | $1,277,000 | +28.9% | 53,476 | -1.4% | 0.00% | 0.0% |
Q3 2019 | $991,000 | -20.0% | 54,242 | +12.0% | 0.00% | 0.0% |
Q2 2019 | $1,239,000 | -15.1% | 48,417 | -3.6% | 0.00% | -50.0% |
Q1 2019 | $1,460,000 | +137.4% | 50,211 | +7.1% | 0.00% | +100.0% |
Q4 2018 | $615,000 | -39.3% | 46,887 | -6.4% | 0.00% | 0.0% |
Q3 2018 | $1,013,000 | -24.9% | 50,100 | -12.2% | 0.00% | 0.0% |
Q2 2018 | $1,349,000 | +5.3% | 57,033 | +0.3% | 0.00% | 0.0% |
Q1 2018 | $1,281,000 | -29.3% | 56,876 | -2.1% | 0.00% | -50.0% |
Q4 2017 | $1,811,000 | +3.2% | 58,088 | +3.4% | 0.00% | 0.0% |
Q3 2017 | $1,755,000 | +107.9% | 56,197 | +14.3% | 0.00% | +100.0% |
Q2 2017 | $844,000 | -1.6% | 49,163 | +0.4% | 0.00% | 0.0% |
Q1 2017 | $858,000 | +51.1% | 48,966 | +13.9% | 0.00% | 0.0% |
Q4 2016 | $568,000 | -9.8% | 42,985 | -1.0% | 0.00% | 0.0% |
Q3 2016 | $630,000 | +46.5% | 43,424 | -0.4% | 0.00% | 0.0% |
Q2 2016 | $430,000 | -14.9% | 43,590 | +6.3% | 0.00% | – |
Q1 2016 | $505,000 | -30.9% | 41,016 | +1.8% | 0.00% | -100.0% |
Q4 2015 | $731,000 | -1.2% | 40,309 | +1.1% | 0.00% | 0.0% |
Q3 2015 | $740,000 | -21.8% | 39,851 | +2.8% | 0.00% | 0.0% |
Q2 2015 | $946,000 | +39.9% | 38,755 | +19.2% | 0.00% | 0.0% |
Q1 2015 | $676,000 | +38.2% | 32,500 | +2.9% | 0.00% | 0.0% |
Q4 2014 | $489,000 | +16.7% | 31,583 | -1.7% | 0.00% | 0.0% |
Q3 2014 | $419,000 | -17.7% | 32,116 | +26.1% | 0.00% | 0.0% |
Q2 2014 | $509,000 | +0.6% | 25,475 | -4.2% | 0.00% | 0.0% |
Q1 2014 | $506,000 | +11.0% | 26,579 | -0.8% | 0.00% | 0.0% |
Q4 2013 | $456,000 | +35.3% | 26,789 | +24.1% | 0.00% | 0.0% |
Q3 2013 | $337,000 | +30.6% | 21,588 | 0.0% | 0.00% | – |
Q2 2013 | $258,000 | – | 21,588 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |